OPT-821
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for OPT-821, covering 2017-09-06 to 2025-06-05. Get the full timeline:
Most recent: Clinical Trial Update: Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma [Phase 1, Phase 2]